Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinsons Disease
Fulleylove-Krause, B.; Sison, S.; Ebert, A.
Show abstract
Parkinsons disease (PD) is a common neurodegenerative disorder caused by the loss of dopaminergic neurons in the substantia nigra that leads to severe motor and non-motor deficits. Although the underlying mechanisms of dopaminergic neuron loss is not entirely clear, increasing evidence suggests mitochondrial malfunction as a key contributor to disease pathogenesis. Recently, we found that human PD patient stem cell-derived dopaminergic neurons exhibit reduced nicotinamide adenine dinucleotide (NAD+) levels, an essential cofactor in mitochondrial function and cellular metabolism. In addition, we found that sirtuins, a group of NAD+-dependent deacetylase enzymes that participate in the regulation of mitochondrial function, energy production, and cell survival, displayed decreased activity in PD dopaminergic neurons, thereby suggesting a potential mechanism for dopaminergic loss in PD. Thus, here we tested whether treatment of PD stem cell-derived dopaminergic neurons with an NAD+ precursor could increase NAD+ levels and improve sirtuin activity.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Dopamine and cortical iPSC-derived neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction: implications for protein deposition versus selective cell loss 96%
- Neuroprotection of low dose carbon monoxide in Parkinson's disease models commensurate with the reduced risk of Parkinson's among smokers 94%
- The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson's disease 94%
Similar papers in this journal
- The PINK1 - Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells 95%
- Queuine, a bacterial derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration 94%
- Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for a randomised controlled clinical trial 93%
Similar papers in this journal
- Asymptomatic carriers of the p.A53T SNCA mutation: data from the PPMI study 95%
- impaired bed mobility in prediagnostic and de novo Parkinson’s disease 94%
- MAPT allele and haplotype frequencies in Nigerian Africans: population distribution and association with Parkinson’s disease risk and age at onset 94%
Similar papers in this journal
- Synergistic Effect of Serotonin 1A and Serotonin 1B/D Receptor Agonists in the Treatment of L-DOPA-Induced Dyskinesia in 6-Hydroxydopamine-Lesioned Rats 93%
- Dopamine D3 Receptor Ligand Suppresses the Expression of Levodopa-Induced Dyskinesia in Nonhuman Primate Model of Parkinson's Disease 93%
- Oscillations of pause-burst neurons in the STN correlate with the severity of motor signs in Parkinson’s disease 93%
Similar papers in this journal
- Characterization of isolated human astrocytes from aging brain 95%
- Different RNA profiles in plasma derived small and large extracellular vesicles of Neurodegenerative diseases patients. 94%
- Thermal cycling-hyperthermia attenuates rotenone-induced cell injury in SH-SY5Y cells through heat-activated mechanisms 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.